XML 50 R21.htm IDEA: XBRL DOCUMENT
v3.19.3

Stockholders' Equity | 6 Months Ended
--- | ---
Sep. 30, 2019
Equity [Abstract] |
Stockholders' Equity | Note 15 — Stockholders' Equity Issuance of Common Stock in the Public Offering On July 25, 2019, in a registered direct public offering, the Company entered into securities purchase agreements with certain institutional investors pursuant to which the Company sold a total of 5,000,000 shares of the its common stock at a price per share of $2.10. The gross proceeds to the Company were $10.5 million. The net proceeds of the offering to the Company were $9.6 million, after deducting placement agent fees and other offering expenses totaling $0.9 million paid by the Company. Issuance of Common Stock for Services to Consultants During the six months ended September 30, 2019, the Company issued 559,586 shares of its common stock valued at $2.5 million to certain Company consultants and vendors. Additionally, the Company has $0.3 million in Accounts Payable and accrued liabilities for stock earned by its consultants, but not yet issued. During the three and six months ended September 30, 2019, the Company recorded $0.2 million and $0.4 million, respectively, of expense related to stock issuances to its consultants. The remaining unrecognized compensation cost of approximately $0.5 million is expected to be recorded over the next year as the shares vest. During the six months ended September 30, 2018, the Company issued 143,523 shares of its common stock valued at $0.7 million to certain Company consultants. During the three and six months ended September 30, 2018, the Company recorded $0.5 million and $1.2 million, respectively, of expense related to stock issuances to consultants. Issuance of Common Stock for Services to Employees During the three and six months ended September 30, 2019, the Company recorded less than $0.1 million, respectively, of expense related to prior stock issuances to employees. As of September 30, 2019, there was no remaining unrecognized compensation cost. During the three and six months ended September 30, 2018, the Company recorded $0.2 million and $0.3 million, respectively, of expense related to the stock issuances to employees. Additional details of the Company's issuances of its common stock to its employees during the six months ended September 30, 2019 are as follows:
|  | Number of Shares |  |  | Weighted- Average Grant Date Fair Value per Share |
Non-vested as of March 31, 2019 |  |  | 15,278 |  |  | $ | 5.01 |
Granted |  |  | - |  |  |  | - |
Vested |  |  | (15,278 | ) |  |  | 5.01 |
Forfeited or expired |  |  | - |  |  |  | - |
Non-vested as of September 30, 2019 |  |  | - |  |  |  | - |
Warrants The table below summarizes the Company's warrant activities during the six months ended September 30, 2019:
|  | Number of Warrants |  |  | Weighted Average Exercise Price |  |  | Weighted- Average Remaining Contractual Term (in years) |
Balance outstanding, March 31, 2019 |  |  | 167,363 |  |  |  | 4.01 |  |  |  | 1.94 |
Granted |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |
Forfeited/expired |  |  | - |  |  |  | - |  |  |  | - |
Balance outstanding, September 30, 2019 |  |  | 167,363 |  |  |  | 4.01 |  |  |  | 1.44 |
Exercisable, September 30, 2019 |  |  | 167,363 |  |  |  | 4.01 |  |  |  | 1.44 |
At September 30, 2019, the intrinsic value of warrants outstanding and exercisable was $0.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration